Shehnaaz Suliman

Directeur/Membre du Conseil chez ULTRAGENYX PHARMACEUTICAL INC.

Fortune : 1 M $ au 31/10/2024

52 ans

Health Technology

Consumer Services

Commercial Services

Profil

Shehnaaz Suliman is currently the Chief Executive Officer & Director at ReCode Therapeutics, Inc. She also serves as the Chairman at Executive Women in Bio.
In addition, she holds positions as an Independent Director at Ultragenyx Pharmaceutical, Inc. and 10X Genomics, Inc. Previously, she worked as a Director at Parvus Therapeutics, Inc. from 2017 to 2019.
Prior to that, she was the Vice President & Head-Global Therapeutic at Roche Holding AG from 2015 to 2017.
She also served as the Senior VP-Corporate Development & Strategy at Theravance Biopharma, Inc. from 2017 to 2019.
From 2021 to 2022, she was the Chief Operating & Business Officer at Alector, Inc. Dr. Suliman obtained a graduate degree and an MBA from the University of Oxford.
She also holds an undergraduate degree and a doctorate from the University of Cape Town.
Additionally, she earned an MBA from Saïd Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ULTRAGENYX PHARMACEUTICAL, INC. 0,02%	18/06/2024	20 200 ( 0,02% )	1 M $	31/10/2024
10X GENOMICS INC CLASS A 0,01%	11/06/2024	13 259 ( 0,01% )	212 542 $	31/10/2024

Dernières actualités sur Shehnaaz Suliman

Alector, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-13-2021 11:45 AM	13/09/21
Les actions du secteur de la santé en baisse juste avant la clôture de mercredi	08/09/21	MT
Le directeur de l'exploitation et le directeur médical d'Alector quittent leurs fonctions	07/09/21	MT
Alector, Inc. - Special Call	29/07/21
Alector, Inc. Presents at BofA Napa Healthcare Conference, Jun-14-2021 05:30 PM	14/06/21

Postes actifs de Shehnaaz Suliman

Sociétés	Poste	Début
ULTRAGENYX PHARMACEUTICAL INC.	Directeur/Membre du Conseil	30/01/2019
10X GENOMICS, INC.	Directeur/Membre du Conseil	01/08/2019
Executive Women in Bio Executive Women in Bio Miscellaneous Commercial ServicesCommercial Services Executive Women in Bio provides mentoring program services to support women in various stages of career and personal development.	Président	-
ReCode Therapeutics, Inc. ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.	Directeur Général	11/01/2022

Tous les postes actifs de Shehnaaz Suliman

Anciens postes connus de Shehnaaz Suliman

Sociétés	Poste	Fin
ALECTOR, INC.	Directeur Général	15/12/2021
Parvus Therapeutics, Inc. Parvus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Parvus Therapeutics, Inc. manufactures and sells biopharmaceutical products. The private company is based in Calgary, Canada.	Directeur/Membre du Conseil	01/07/2019
THERAVANCE BIOPHARMA, INC.	Corporate Officer/Principal	31/03/2019
ROCHE HOLDING AG	Corporate Officer/Principal	01/07/2017

Voir l'expérience en détail de Shehnaaz Suliman

Formation de Shehnaaz Suliman

Saïd Business School	Masters Business Admin
University of Oxford	Graduate Degree
University of Cape Town	Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées